191
Access to "Expensive" Medical Technologies
Access to "Expensive" Medical Technologies
Abstract Submissions Closed
Saturday, 27 February 2021: 14:15-15:45
Location:
RC15 Sociology of Health (host committee)
Language: English
Session Type: Oral
There is evidence of major social inequalities in access to "expensive" medical technologies, particularly expensive medicines, within and between countries and these will be widening due to increasing pressure on resources particularly in publicly funded health systems. "Expensive" technology is a relative concept and its significance will depend on the socio-economic environment and on the cultural meaning assigned to its use. The session will focus on papers involving both theoretical and empirical analysis about gaining access to "expensive" technologies in different health systems in high and low to middle income countries. The session aims to throw light on what pathways patients navigate and negotiate to gain access and the cultural and socio-political influences that enable or provide obstacles to gaining access. Papers can focus on either consumption/demand and/or production/supply side pathways and influences. Examples on the demand side are the use by patients and their relatives of litigation to gain access. Examples on the supply side might include the decision making (front stage/back stage) of rationing or priority setting health agencies, such as CONITEC in Brazil and NICE in England, and how powerful corporate interest groups such as the drug industry may shape these decisions. The organization of the local health system and local culture may also be important influences in shaping different patterns of access to medicines.
Session Organizers: